X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
GSK Pharma Fact Sheet, GSK Pharma Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK Pharma Fact Sheet   (GLXO)

Here is the latest financial fact sheet of GSK Pharma. For more details, see the GSK Pharma quarterly results and GSK Pharma share price and chart. For a sector overview, read our pharmaceuticals sector report.

GSK PHARMA Price History

Price Rs 1,381.9
Mkt Cap Rs m 234,094
Vol '000 0.2
P/E X 60.9
P/CF X 60.2
EPS (TTM) Rs 22.7
% ch % -0.4
No. of shares m 169.41
% ch week % 0.3
% ch 1-mth % -1.3
% ch 12-mth % 13.1
52 week H/L Rs 1,812.0/1,020.0
(As on Dec 13, 2018 11:13:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

GSK PHARMA Financials

No. of Mths
Year Ending
12
Dec-13
15
Mar-15
12
Mar-16
12
Mar-17
12
Mar-18
5-Yr Chart
Click to enlarge
GSK PHARMA EQUITY SHARE DATA
High Rs3,0023,5503,8503,8382,760 
Low Rs2,0052,3522,9662,6372,040 
Sales per share (Unadj.) Rs302.6396.5335.1343.4339.0 
Earnings per share (Unadj.) Rs56.955.744.439.841.4 
Diluted earnings per shareRs28.427.822.219.920.7 
Cash flow per share (Unadj.) Rs59.258.747.442.945.9 
Dividends per share (Unadj.) Rs50.0062.5050.0030.0035.00 
Adj. dividends per shareRs25.0031.2525.0015.0017.50 
Dividend yield (eoy) %2.02.11.50.91.5 
Book value per share (Unadj.) Rs234.9288.6257.8236.9242.9 
Adj. book value per shareRs117.5144.3128.9118.5121.4 
Shares outstanding (eoy) m84.7084.7084.7084.7084.70 
Bonus/Rights/Conversions  ----- 
Price / Sales ratio x8.37.410.29.47.1 
Avg P/E ratio x44.053.076.781.457.9 
P/CF ratio (eoy) x42.350.372.075.552.3 
Price / Book Value ratio x10.710.213.213.79.9 
Dividend payout %87.9112.2112.675.484.5 
Avg Mkt Cap Rs m212,038249,933288,643274,216203,280 
No. of employees `0005.04.74.64.7NA 
Total wages/salary Rs m3,6214,9304,4344,8305,234 
Avg. sales/employee Rs Th5,090.87,211.76,154.76,192.2NM 
Avg. wages/employee Rs Th719.31,058.6961.61,028.3NM 
Avg. net profit/employee Rs Th956.91,012.7815.8717.1NM 
GSK PHARMA INCOME DATA
Net Sales Rs m25,62733,58528,37929,08528,715 
Other income Rs m1,7701,9991,228731545 
Total revenues Rs m27,39735,58429,60729,81629,260 
Gross profit Rs m5,2826,2834,7834,1905,059 
Depreciation Rs m199254250263380 
Interest Rs m00032 
Profit before tax Rs m6,8538,0285,7614,6555,222 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m262-51923457178 
Tax Rs m2,2982,7932,0231,7441,892 
Profit after tax Rs m4,8174,7163,7613,3683,508 
Gross profit margin %20.618.716.914.417.6 
Effective tax rate %33.534.835.137.536.2 
Net profit margin %18.814.013.311.612.2 
GSK PHARMA BALANCE SHEET DATA
Current assets Rs m26,23925,87021,73716,74221,815 
Current liabilities Rs m8,8895,0025,7927,20215,999 
Net working cap to sales %67.762.156.232.820.3 
Current ratio x3.05.23.82.31.4 
Inventory Days Days4941685364 
Debtors Days Days1411162119 
Net fixed assets Rs m1,6202,4444,7778,63512,475 
Share capital Rs m847847847847847 
"Free" reserves Rs m19,03323,59420,98519,22219,726 
Net worth Rs m19,89724,44121,83220,06920,573 
Long term debt Rs m362616106 
Total assets Rs m31,29532,24430,54930,03839,475 
Interest coverage xNMNMNM1,552.72,612.0 
Debt to equity ratio x00000 
Sales to assets ratio x0.81.00.91.00.7 
Return on assets %15.414.612.311.28.9 
Return on equity %24.219.317.216.817.1 
Return on capital %35.730.726.525.526.2 
Exports to sales %0.40.2000 
Imports to sales %12.312.914.900 
Exports (fob) Rs m9563400 
Imports (cif) Rs m3,1594,3344,23700 
Fx inflow Rs m625699519528564 
Fx outflow Rs m5,3807,6808,3207,1937,429 
Net fx Rs m-4,755-6,981-7,801-6,665-6,865 
GSK PHARMA CASH FLOW
From Operations Rs m 2,813 3,409 1,389 2,344 4,728 
From Investments Rs m 1,890 1,776 4,990 3,006 -1,042 
From Financial Activity Rs m -4,941 -4,970 -6,383 -5,108 -3,066 
Net Cashflow Rs m -239 215 -4 242 620 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 0.0%
Foreign collaborators 50.7%
Indian inst/Mut Fund 10.2%
FIIs 23.8%
ADR/GDR 0.0%
Free float 15.4%
Shareholders 102,036
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF Dr. Annie Besant Road, Worli, Mumbai - 400 030
E-MAIL ajay.a.nadkarni@gsk.com WEB www.gsk-india.com
TELEPHONE (022) 2495 9415 FAX (022) 2498 1526
SECTOR PHARMACEUTICALS GROUP M N C
TR AGENT Karvy Computershare, 17-24, Vithalrao Nagar, Madhapur, Hyderabad-81
AUDITOR Price Waterhouse & Co.
CHM: D. S. Parekh COMP SEC: A. A. Nadkarni (GM & Admin) YEAR OF INC: 1924 BSE CODE: 500660 FV (Rs): 10 DIV YIELD (%): 1.3

More Pharmaceuticals Company Fact Sheets:   PANACEA BIOTECH  MERCK LTD  FDC LTD.  SHASUN PHARMA  LUPIN LTD  

Compare GSK PHARMA With:   PANACEA BIOTECH  MERCK LTD  FDC LTD.  SHASUN PHARMA  LUPIN LTD  

Compare GSK PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Strong; PSU & Realty Stocks Lead(09:30 am)

Asian stock markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 1% while the Hang Seng is up 1.3%.

Views on news

GSK PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 22.7% (Quarterly Result Update)

Oct 23, 2018 | Updated on Oct 23, 2018

For the quarter ended September 2018, GSK PHARMA has posted a net profit of Rs 1 bn (down 22.7% YoY). Sales on the other hand came in at Rs 8 bn (down 2.4% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY19); Net Profit Up 235.3% (Quarterly Result Update)

Jul 26, 2018 | Updated on Jul 26, 2018

For the quarter ended June 2018, GSK PHARMA has posted a net profit of Rs 886 m (up 235.3% YoY). Sales on the other hand came in at Rs 7 bn (up 21.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK GSK PHARMA

  • Track your investment in GSK PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON GSK PHARMA

GSK PHARMA - MYLAN COMPARISON

COMPARE GSK PHARMA WITH

MARKET STATS